Dr. Koen Vanhoutte

Dr. Koen Vanhoutte is an Executive Director in pharmaceutical research and development with more than 25 years of industrial experience in analytical chemistry. He holds a PhD in Chemistry from the University of Antwerp, with his early scientific training and core expertise rooted in liquid chromatography–mass spectrometry (LC‑MS) and chromatographic method development. Over the course of his career, he has built extensive experience in Chemistry, Manufacturing and Controls (CMC) across both early‑ and late‑stage pharmaceutical development. He currently leads the Synthetics Analytical Development organization within Johnson & Johnson Innovative Medicine, where he is responsible for defining and delivering analytical strategies across the full product lifecycle, from development through commercial manufacture. His scope includes method development, validation, technology transfer, clinical trial material release, and ICH stability testing for synthetic therapeutics. His involvement in biologics is focused specifically on microbiology‑based analytical methods, and he has extensive experience supporting global regulatory submissions and inspections, including interactions with FDA and EMA. Dr. Vanhoutte is passionate about leading and developing global teams and fostering scientific excellence through people development. He is strongly committed to applying rigorous analytical science to advance therapeutic development, while staying closely connected to evolving analytical methodologies through pragmatic, applied innovation.